data_1cyv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cyv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.366 -0.605 . . . . 10.32 109.366 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 2' ' ' ILE . 7.5 tt -147.01 69.03 11.76 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 6.98 109.645 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.53 -169.17 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.683 2.255 . . . . 5.51 110.451 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 5' ' ' GLY . . . -90.21 58.83 3.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.335 -1.506 . . . . 2.61 109.335 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.488 ' O ' ' HB1' ' A' ' 9' ' ' ALA . . . 45.04 57.55 5.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.248 -1.541 . . . . 1.21 109.248 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' GLY . 0.6 OUTLIER -55.9 -165.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.077 -1.249 . . . . 3.02 109.446 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 74.8 m 61.29 -88.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.166 -0.959 . . . . 1.18 109.042 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 1.2 mm-40 -96.14 89.19 5.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.173 -0.954 . . . . 1.93 109.583 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . . . -172.29 149.58 2.27 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.285 -0.885 . . . . 1.17 110.209 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.21 161.2 44.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 3.09 109.072 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ALA . 34.2 Cg_endo -76.88 107.69 2.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.598 2.198 . . . . 0.62 111.15 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 40' ' ' ALA . . . 32.66 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.147 0.499 . . . . 1.14 111.428 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.587 HG22 ' CE1' ' A' ' 43' ' ' TYR . 0.0 OUTLIER -76.97 172.85 8.63 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.058 -1.026 . . . . 1.15 108.652 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 13' ' ' THR . 32.7 Cg_endo -76.03 -4.98 15.85 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.083 1.855 . . . . 0.52 107.809 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.57 -59.42 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.777 -1.194 . . . . 1.83 107.777 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.596 HG13 ' CG ' ' A' ' 43' ' ' TYR . 38.3 mm -53.84 -47.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.885 -0.598 . . . . 1.11 109.612 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.558 ' HB2' ' CG ' ' A' ' 39' ' ' GLU . 0.5 OUTLIER -59.58 -29.72 68.15 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.36 -0.838 . . . . 1.51 109.139 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.85 -34.28 75.7 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.938 -1.134 . . . . 1.94 107.938 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.548 HG21 ' N ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -61.67 -34.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.622 -1.251 . . . . 1.12 107.622 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.607 ' CG1' ' HA ' ' A' ' 39' ' ' GLU . 8.8 t -71.3 -22.8 22.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.944 -0.761 . . . . 1.2 108.944 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.72 3.1 44.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.958 . . . . 1.5 109.468 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -108.17 -73.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 2.85 109.156 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 19' ' ' ILE . 2.1 t -83.2 -5.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 1.49 109.544 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' N ' ' HD3' ' A' ' 25' ' ' PRO . 1.1 mptp? -129.88 52.13 8.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.265 -0.897 . . . . 1.86 109.792 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 36.1 Cg_endo -74.65 4.84 4.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.256 1.971 . . . . 0.6 110.502 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.822 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 1.8 mt-30 -120.78 -47.36 2.31 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 105.356 -2.09 . . . . 2.57 105.356 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.61 ' CD1' ' CD2' ' A' ' 65' ' ' LEU . 5.6 mt -64.54 -12.9 49.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.618 -0.882 . . . . 2.23 108.618 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HB2' HG11 ' A' ' 20' ' ' VAL . 2.4 tm-20 -94.03 -10.23 34.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.686 -0.634 . . . . 1.24 111.448 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -144.3 20.52 1.73 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.605 -1.309 . . . . 1.81 107.971 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 6.5 ttpp -92.93 -65.75 0.98 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.367 -0.975 . . . . 2.18 108.367 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 59' ' ' ALA . 1.8 t -44.45 -29.77 0.75 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.905 -1.146 . . . . 1.13 107.905 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.538 ' N ' HG21 ' A' ' 31' ' ' THR . 1.2 p30 35.42 42.0 0.1 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.753 0.787 . . . . 2.08 109.504 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -67.3 161.81 24.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 1.9 110.07 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.564 HG21 ' CE1' ' A' ' 35' ' ' TYR . 9.3 t -90.51 38.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -0.8 . . . . 1.49 109.416 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CE1' HG21 ' A' ' 34' ' ' THR . 12.2 m-85 -140.51 -152.57 0.42 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.456 -0.777 . . . . 2.35 108.957 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' CZ ' ' A' ' 58' ' ' ARG . . . -115.5 67.02 0.29 Allowed Glycine 0 N--CA 1.48 1.58 0 N-CA-C 107.697 -2.161 . . . . 0.66 107.697 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.64 ' O ' ' N ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -133.38 31.74 3.73 Favored 'General case' 0 C--O 1.202 -1.424 0 N-CA-C 106.498 -1.668 . . . . 1.95 106.498 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -114.95 60.89 0.69 Allowed 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.355 -1.35 . . . . 1.65 107.355 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 0.2 OUTLIER 179.05 -151.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.878 -1.156 . . . . 1.87 107.878 -176.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 17' ' ' GLN . . . -74.85 158.59 33.15 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.142 -1.023 . . . . 1.11 108.328 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.598 ' CG2' ' CE2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -100.35 -38.55 6.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.106 -1.072 . . . . 1.17 108.106 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 168.84 166.56 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.537 -0.865 . . . . 1.61 109.209 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.596 ' CG ' HG13 ' A' ' 16' ' ' ILE . 2.8 p90 -143.96 118.15 9.54 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.944 -0.762 . . . . 2.19 108.944 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 45' ' ' THR . 0.0 OUTLIER -94.7 151.67 19.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.724 -1.213 . . . . 1.63 107.724 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.549 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -123.5 129.89 51.89 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.532 -1.355 . . . . 1.21 110.402 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 46' ' ' GLN . 10.4 pt20 -152.67 136.27 16.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.416 -0.957 . . . . 2.0 108.416 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.593 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 22.7 m -63.25 -158.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 2.17 110.164 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.617 ' CG1' ' N ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER 164.85 -50.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.127 -1.435 . . . . 1.24 107.127 -177.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.617 ' N ' ' CG1' ' A' ' 48' ' ' VAL . . . 159.5 47.55 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.276 -1.75 . . . . 1.25 106.276 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 51' ' ' THR . . . 155.33 -27.53 0.62 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 106.695 -2.562 . . . . 0.45 106.695 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.629 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 29.1 m 108.96 93.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.439 0.696 . . . . 1.14 110.37 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.469 ' OD1' ' HD3' ' A' ' 68' ' ' LYS . 1.6 t-20 -70.56 153.73 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.489 -0.757 . . . . 0.9 110.098 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' A' ' 51' ' ' THR . 63.5 m-85 -140.57 131.02 25.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 2.23 108.958 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -107.01 92.64 4.16 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.509 -0.744 . . . . 2.28 109.164 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.542 ' CG2' HG22 ' A' ' 16' ' ' ILE . 11.2 mm -94.63 88.22 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.655 -1.278 . . . . 1.19 111.0 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' CG ' HG13 ' A' ' 41' ' ' VAL . 22.6 tttp -79.24 110.22 14.31 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.074 -1.825 . . . . 2.24 106.074 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.543 ' CG2' HD11 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.05 147.12 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.069 -1.452 . . . . 1.28 110.639 -177.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.594 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.01 140.62 30.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.679 -0.692 . . . . 1.88 110.012 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HB3' HD12 ' A' ' 65' ' ' LEU . . . -133.28 26.42 4.16 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.04 . . . . 1.02 108.193 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 37' ' ' LYS . . . 111.03 179.74 20.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.341 -1.504 . . . . 0.44 109.341 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -1.202 . . . . 1.41 109.349 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.9 -39.29 3.72 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.3 -0.875 . . . . 1.74 109.79 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 5.0 mttp -98.12 157.45 16.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 2.21 108.606 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.598 ' CE2' ' CG2' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -166.01 137.66 3.8 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.526 -1.359 . . . . 2.59 109.148 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.61 ' CD2' ' CD1' ' A' ' 27' ' ' LEU . 3.7 mp -119.89 -177.26 3.36 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.154 -1.018 . . . . 1.16 109.436 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' ND1' ' HG3' ' A' ' 56' ' ' LYS . 3.3 t60 -162.96 154.14 17.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.347 -1.341 . . . . 0.4 111.048 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.736 ' HG ' ' N ' ' A' ' 68' ' ' LYS . 25.0 tp -157.42 164.29 37.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.001 0.905 . . . . 1.09 109.045 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.736 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.01 99.15 3.69 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.521 -2.029 . . . . 1.11 105.521 176.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.598 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 90.1 t -82.25 134.43 27.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 117.177 -1.809 . . . . 1.17 108.388 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.6 ' CZ ' ' CG1' ' A' ' 48' ' ' VAL . 3.3 t80 -139.73 122.03 15.98 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.608 -1.308 . . . . 2.17 110.883 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 25.8 mttt -89.58 67.98 7.62 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.035 -1.098 . . . . 2.61 108.035 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.585 ' HA ' ' CZ ' ' A' ' 70' ' ' PHE . 3.2 m -40.25 131.94 2.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.941 0.877 . . . . 0.91 111.25 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.578 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -179.16 60.52 0.12 Allowed Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.785 -1.191 . . . . 1.31 107.785 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 73' ' ' LEU . 38.0 Cg_endo -81.02 49.64 3.3 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.735 2.29 . . . . 0.6 110.931 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.22 -48.43 3.62 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.639 -1.385 . . . . 0.77 109.639 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -74.64 -17.87 60.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 2.76 109.553 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 56.73 93.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.99 109.298 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 79' ' ' ASP . 49.7 mt-10 -132.01 79.01 1.84 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 2.45 109.401 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER 45.73 -166.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 1.52 109.38 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.532 ' O ' ' CG2' ' A' ' 81' ' ' VAL . 0.7 OUTLIER -100.34 -147.07 0.35 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 1.5 110.247 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER 179.2 160.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.409 -0.96 . . . . 1.22 108.409 -178.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.598 ' HG ' ' HA ' ' A' ' 69' ' ' VAL . 1.8 mp -146.91 73.92 1.33 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.161 -0.962 . . . . 1.13 109.495 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -55.15 -8.86 0.33 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.61 -0.836 . . . . 1.29 109.236 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.586 ' HA3' ' HB2' ' A' ' 68' ' ' LYS . . . -115.72 151.93 18.21 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.011 -1.566 . . . . 0.48 109.676 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 40.3 p90 165.71 121.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.394 -0.965 . . . . 2.71 108.394 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.523 ' CB ' ' OD2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -162.72 154.8 18.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 1.92 110.703 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 65' ' ' LEU . 4.2 p -90.01 -144.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.578 -0.897 . . . . 1.25 108.578 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 89' ' ' LYS . 17.7 p-10 -130.19 -144.34 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.471 -1.393 . . . . 2.7 110.109 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 8.7 tttt 81.88 55.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.756 . . . . 2.72 109.361 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 89' ' ' LYS . 0.9 OUTLIER 39.9 37.58 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.654 -0.654 . . . . 1.67 110.557 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 88' ' ' ASP . 45.3 mttt -105.45 -61.24 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 2.0 108.871 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 86' ' ' GLN . 2.3 t0 -76.91 6.88 5.47 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.627 -0.829 . . . . 2.23 109.014 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -52.93 149.1 6.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 1.81 109.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' OE1' HG21 ' A' ' 2' ' ' ILE . 2.0 mm-40 -179.1 135.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 2.86 109.305 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.27 163.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 3.33 109.295 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.406 ' CG2' ' HE2' ' A' ' 56' ' ' LYS . 66.0 p -132.12 164.23 26.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.948 . . . . 3.48 109.526 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -99.36 -30.56 6.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.616 -1.394 . . . . 3.52 109.616 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 7.52 109.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.366 -0.605 . . . . 10.09 109.366 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 2' ' ' ILE . 7.5 tt -147.01 69.03 11.76 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 6.4100000000000001 109.645 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.592 ' HG2' HD23 ' A' ' 6' ' ' LEU . 34.9 Cg_endo -77.53 -169.17 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.683 2.255 . . . . 4.9000000000000004 110.451 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 5' ' ' GLY . . . -90.21 58.83 3.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.335 -1.506 . . . . 2.3500000000000001 109.335 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 9' ' ' ALA . . . 45.04 57.55 5.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.248 -1.541 . . . . 1.01 109.248 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' HG2' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -55.9 -165.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.077 -1.249 . . . . 2.46 109.446 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 74.8 m 61.29 -88.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.166 -0.959 . . . . 0.60999999999999999 109.042 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 1.2 mm-40 -96.14 89.19 5.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.173 -0.954 . . . . 1.9299999999999999 109.583 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -172.29 149.58 2.27 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.285 -0.885 . . . . 0.46000000000000002 110.209 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.21 161.2 44.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 2.5899999999999999 109.072 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ALA . 34.2 Cg_endo -76.88 107.69 2.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.598 2.198 . . . . 0.56999999999999995 111.15 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.901 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 32.66 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.147 0.499 . . . . 0.48999999999999999 111.428 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -76.97 172.85 8.63 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.058 -1.026 . . . . 0.42999999999999999 108.652 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.736 ' HD2' HG22 ' A' ' 13' ' ' THR . 32.7 Cg_endo -76.03 -4.98 15.85 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.083 1.855 . . . . 0.47999999999999998 107.809 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' H ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -103.57 -59.42 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.777 -1.194 . . . . 1.8300000000000001 107.777 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 55' ' ' ILE . 38.3 mm -53.84 -47.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.885 -0.598 . . . . 0.32000000000000001 109.612 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.752 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -59.58 -29.72 68.15 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.36 -0.838 . . . . 1.1299999999999999 109.139 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.85 -34.28 75.7 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.938 -1.134 . . . . 1.9399999999999999 107.938 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -61.67 -34.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.622 -1.251 . . . . 0.46999999999999997 107.622 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.914 HG11 ' HA ' ' A' ' 39' ' ' GLU . 8.8 t -71.3 -22.8 22.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.944 -0.761 . . . . 0.53000000000000003 108.944 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.72 3.1 44.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.958 . . . . 1.5 109.468 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -108.17 -73.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 2.52 109.156 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' ' HD2' ' A' ' 24' ' ' LYS . 2.1 t -83.2 -5.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.89000000000000001 109.544 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.62 ' HG2' HD22 ' A' ' 65' ' ' LEU . 1.1 mptp? -129.88 52.13 8.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.265 -0.897 . . . . 1.3500000000000001 109.792 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 36.1 Cg_endo -74.65 4.84 4.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.256 1.971 . . . . 0.55000000000000004 110.502 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.836 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 1.8 mt-30 -120.78 -47.36 2.31 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 105.356 -2.09 . . . . 1.99 105.356 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.091 HD13 ' CD2' ' A' ' 65' ' ' LEU . 5.6 mt -64.54 -12.9 49.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.618 -0.882 . . . . 1.55 108.618 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.574 ' HB2' HG12 ' A' ' 20' ' ' VAL . 2.4 tm-20 -94.03 -10.23 34.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.686 -0.634 . . . . 1.24 111.448 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -144.3 20.52 1.73 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.605 -1.309 . . . . 1.8100000000000001 107.971 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.836 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 6.5 ttpp -92.93 -65.75 0.98 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.367 -0.975 . . . . 1.6799999999999999 108.367 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.698 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.8 t -44.45 -29.77 0.75 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.905 -1.146 . . . . 0.42999999999999999 107.905 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 31' ' ' THR . 1.2 p30 35.42 42.0 0.1 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.753 0.787 . . . . 1.3899999999999999 109.504 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 31' ' ' THR . 1.2 mm-40 -67.3 161.81 24.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 1.8999999999999999 110.07 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.681 HG23 ' CE1' ' A' ' 35' ' ' TYR . 9.3 t -90.51 38.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -0.8 . . . . 1.1799999999999999 109.416 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.681 ' CE1' HG23 ' A' ' 34' ' ' THR . 12.2 m-85 -140.51 -152.57 0.42 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.456 -0.777 . . . . 1.54 108.957 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' CZ ' ' A' ' 58' ' ' ARG . . . -115.5 67.02 0.29 Allowed Glycine 0 N--CA 1.48 1.58 0 N-CA-C 107.697 -2.161 . . . . 0.64000000000000001 107.697 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 1.05 ' C ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.38 31.74 3.73 Favored 'General case' 0 C--O 1.202 -1.424 0 N-CA-C 106.498 -1.668 . . . . 1.1399999999999999 106.498 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.05 HD13 ' C ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -114.95 60.89 0.69 Allowed 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.355 -1.35 . . . . 1.0700000000000001 107.355 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.914 ' HA ' HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER 179.05 -151.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.878 -1.156 . . . . 1.8700000000000001 107.878 -176.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.901 ' O ' ' HB2' ' A' ' 12' ' ' ALA . . . -74.85 158.59 33.15 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.142 -1.023 . . . . 0.35999999999999999 108.328 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.099 HG21 ' CE2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -100.35 -38.55 6.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.106 -1.072 . . . . 0.41999999999999998 108.106 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.645 ' NE2' ' HB3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER 168.84 166.56 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.537 -0.865 . . . . 1.4399999999999999 109.209 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.616 ' CG ' HG13 ' A' ' 16' ' ' ILE . 2.8 p90 -143.96 118.15 9.54 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.944 -0.762 . . . . 1.3100000000000001 108.944 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -94.7 151.67 19.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.724 -1.213 . . . . 0.93999999999999995 107.724 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.56 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -123.5 129.89 51.89 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.532 -1.355 . . . . 0.64000000000000001 110.402 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.4 pt20 -152.67 136.27 16.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.416 -0.957 . . . . 1.5900000000000001 108.416 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 22.7 m -63.25 -158.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 1.5 110.164 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.627 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER 164.85 -50.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.127 -1.435 . . . . 0.62 107.127 -177.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HB1' ' HA ' ' A' ' 74' ' ' PRO . . . 159.5 47.55 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.276 -1.75 . . . . 0.63 106.276 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 51' ' ' THR . . . 155.33 -27.53 0.62 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 106.695 -2.562 . . . . 0.42999999999999999 106.695 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.629 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 29.1 m 108.96 93.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.439 0.696 . . . . 0.42999999999999999 110.37 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.472 ' OD1' ' HD3' ' A' ' 68' ' ' LYS . 1.6 t-20 -70.56 153.73 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.489 -0.757 . . . . 0.64000000000000001 110.098 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.619 ' CE1' HG22 ' A' ' 51' ' ' THR . 63.5 m-85 -140.57 131.02 25.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 1.3100000000000001 108.958 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -107.01 92.64 4.16 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.509 -0.744 . . . . 1.3999999999999999 109.164 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 16' ' ' ILE . 11.2 mm -94.63 88.22 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.655 -1.278 . . . . 0.47999999999999998 111.0 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.718 ' HG3' ' CD2' ' A' ' 66' ' ' HIS . 22.6 tttp -79.24 110.22 14.31 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.074 -1.825 . . . . 1.7 106.074 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.05 147.12 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.069 -1.452 . . . . 0.53000000000000003 110.639 -177.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 1.073 ' HB2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.01 140.62 30.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.679 -0.692 . . . . 1.1599999999999999 110.012 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.965 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . . . -133.28 26.42 4.16 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.04 . . . . 0.32000000000000001 108.193 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 37' ' ' LYS . . . 111.03 179.74 20.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.341 -1.504 . . . . 0.44 109.341 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -1.202 . . . . 1.4099999999999999 109.349 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.9 -39.29 3.72 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.3 -0.875 . . . . 1.74 109.79 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' C ' ' HB3' ' A' ' 59' ' ' ALA . 5.0 mttp -98.12 157.45 16.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 1.6699999999999999 108.606 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 1.099 ' CE2' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -166.01 137.66 3.8 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.526 -1.359 . . . . 1.6899999999999999 109.148 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.091 ' CD2' HD13 ' A' ' 27' ' ' LEU . 3.7 mp -119.89 -177.26 3.36 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.154 -1.018 . . . . 0.44 109.436 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.718 ' CD2' ' HG3' ' A' ' 56' ' ' LYS . 28.8 t-80 -162.96 154.14 17.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.347 -1.341 . . . . 0.38 111.048 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.108 HD11 ' CD2' ' A' ' 82' ' ' LEU . 25.0 tp -157.42 164.29 37.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.001 0.905 . . . . 0.37 109.045 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.746 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.01 99.15 3.69 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.521 -2.029 . . . . 0.45000000000000001 105.521 176.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.6 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 90.1 t -82.25 134.43 27.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 117.177 -1.809 . . . . 0.38 108.388 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.627 ' CZ ' HG11 ' A' ' 48' ' ' VAL . 3.3 t80 -139.73 122.03 15.98 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.608 -1.308 . . . . 1.27 110.883 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.419 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 25.8 mttt -89.58 67.98 7.62 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.035 -1.098 . . . . 2.1600000000000001 108.035 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.595 ' HA ' ' CZ ' ' A' ' 70' ' ' PHE . 3.2 m -40.25 131.94 2.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.941 0.877 . . . . 0.72999999999999998 111.25 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -179.16 60.52 0.12 Allowed Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.785 -1.191 . . . . 0.52000000000000002 107.785 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.809 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . 38.0 Cg_endo -81.02 49.64 3.3 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.735 2.29 . . . . 0.59999999999999998 110.931 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.22 -48.43 3.62 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.639 -1.385 . . . . 0.77000000000000002 109.639 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -74.64 -17.87 60.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 2.1800000000000002 109.553 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.8 t30 56.73 93.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.98999999999999999 109.298 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 79' ' ' ASP . 49.7 mt-10 -132.01 79.01 1.84 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 2.4500000000000002 109.401 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER 45.73 -166.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 1.52 109.38 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.869 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -100.34 -147.07 0.35 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 0.85999999999999999 110.247 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.008 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.9 OUTLIER 179.2 160.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.409 -0.96 . . . . 0.54000000000000004 108.409 -178.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 1.108 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.8 mp -146.91 73.92 1.33 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.161 -0.962 . . . . 0.45000000000000001 109.495 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.4 ' OG1' ' HE2' ' A' ' 68' ' ' LYS . 1.5 m -55.15 -8.86 0.33 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.61 -0.836 . . . . 0.57999999999999996 109.236 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.938 ' O ' HD12 ' A' ' 67' ' ' LEU . . . -115.72 151.93 18.21 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.011 -1.566 . . . . 0.46999999999999997 109.676 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 40.3 p90 165.71 121.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.394 -0.965 . . . . 1.8899999999999999 108.394 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.523 ' CB ' ' OD2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -162.72 154.8 18.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 1.9199999999999999 110.703 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.823 HG13 ' N ' ' A' ' 88' ' ' ASP . 4.2 p -90.01 -144.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.578 -0.897 . . . . 0.80000000000000004 108.578 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.823 ' N ' HG13 ' A' ' 87' ' ' VAL . 17.7 p-10 -130.19 -144.34 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.471 -1.393 . . . . 2.7000000000000002 110.109 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 8.7 tttt 81.88 55.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.756 . . . . 2.2400000000000002 109.361 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 89' ' ' LYS . 5.8 p30 39.9 37.58 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.654 -0.654 . . . . 1.6699999999999999 110.557 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 88' ' ' ASP . 45.3 mttt -105.45 -61.24 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 1.45 108.871 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 86' ' ' GLN . 2.3 t0 -76.91 6.88 5.47 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.627 -0.829 . . . . 2.23 109.014 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -52.93 149.1 6.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 1.8100000000000001 109.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.425 ' OE1' ' CG2' ' A' ' 2' ' ' ILE . 2.0 mm-40 -179.1 135.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 2.8599999999999999 109.305 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.27 163.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 2.7400000000000002 109.295 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.403 ' CG2' ' HE2' ' A' ' 56' ' ' LYS . 66.0 p -132.12 164.23 26.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.948 . . . . 2.9700000000000002 109.526 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -99.36 -30.56 6.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.616 -1.394 . . . . 3.52 109.616 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 6.7400000000000002 109.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.366 -0.605 . . . . 10.09 109.366 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.786 ' O ' HG23 ' A' ' 2' ' ' ILE . 7.5 tt -147.01 69.03 11.76 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.34 -0.85 . . . . 6.41 109.645 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.592 ' HG2' HD23 ' A' ' 6' ' ' LEU . 34.9 Cg_endo -77.53 -169.17 0.69 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.683 2.255 . . . . 4.9 110.451 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 5' ' ' GLY . . . -90.21 58.83 3.51 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.335 -1.506 . . . . 2.35 109.335 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 9' ' ' ALA . . . 45.04 57.55 5.42 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.248 -1.541 . . . . 1.01 109.248 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.592 HD23 ' HG2' ' A' ' 3' ' ' PRO . 0.6 OUTLIER -55.9 -165.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.077 -1.249 . . . . 2.46 109.446 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 74.8 m 61.29 -88.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.166 -0.959 . . . . 0.61 109.042 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 1.2 mm-40 -96.14 89.19 5.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.173 -0.954 . . . . 1.93 109.583 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' A' ' 44' ' ' LYS . . . -172.29 149.58 2.27 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.285 -0.885 . . . . 0.46 110.209 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -122.21 161.2 44.23 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 2.59 109.072 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' O ' ' O ' ' A' ' 12' ' ' ALA . 34.2 Cg_endo -76.88 107.69 2.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.598 2.198 . . . . 0.57 111.15 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.901 ' HB2' ' O ' ' A' ' 40' ' ' ALA . . . 32.66 100.17 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.147 0.499 . . . . 0.49 111.428 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.736 HG22 ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -76.97 172.85 8.63 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.058 -1.026 . . . . 0.43 108.652 178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.736 ' HD2' HG22 ' A' ' 13' ' ' THR . 32.7 Cg_endo -76.03 -4.98 15.85 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.083 1.855 . . . . 0.48 107.809 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' H ' ' HB ' ' A' ' 13' ' ' THR . 0.7 OUTLIER -103.57 -59.42 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.777 -1.194 . . . . 1.83 107.777 179.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 55' ' ' ILE . 38.3 mm -53.84 -47.5 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.885 -0.598 . . . . 0.32 109.612 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.752 ' HA ' ' HB2' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -59.58 -29.72 68.15 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.36 -0.838 . . . . 1.13 109.139 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.85 -34.28 75.7 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.938 -1.134 . . . . 1.94 107.938 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.798 HG22 ' O ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -61.67 -34.43 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.622 -1.251 . . . . 0.47 107.622 178.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.914 HG11 ' HA ' ' A' ' 39' ' ' GLU . 8.8 t -71.3 -22.8 22.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.944 -0.761 . . . . 0.53 108.944 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.72 3.1 44.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.168 -0.958 . . . . 1.5 109.468 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -108.17 -73.41 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 2.52 109.156 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' ' HD2' ' A' ' 24' ' ' LYS . 2.1 t -83.2 -5.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.89 109.544 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.62 ' HG2' HD22 ' A' ' 65' ' ' LEU . 1.1 mptp? -129.88 52.13 8.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.265 -0.897 . . . . 1.35 109.792 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' N ' ' A' ' 24' ' ' LYS . 36.1 Cg_endo -74.65 4.84 4.21 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.256 1.971 . . . . 0.55 110.502 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.836 ' O ' ' HB2' ' A' ' 30' ' ' LYS . 1.8 mt-30 -120.78 -47.36 2.31 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 105.356 -2.09 . . . . 1.99 105.356 177.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.091 HD13 ' CD2' ' A' ' 65' ' ' LEU . 5.6 mt -64.54 -12.9 49.44 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.618 -0.882 . . . . 1.55 108.618 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.574 ' HB2' HG12 ' A' ' 20' ' ' VAL . 2.4 tm-20 -94.03 -10.23 34.18 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.686 -0.634 . . . . 1.24 111.448 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -144.3 20.52 1.73 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.605 -1.309 . . . . 1.81 107.971 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.836 ' HB2' ' O ' ' A' ' 26' ' ' GLN . 6.5 ttpp -92.93 -65.75 0.98 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.367 -0.975 . . . . 1.68 108.367 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.698 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.8 t -44.45 -29.77 0.75 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.905 -1.146 . . . . 0.43 107.905 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.476 ' C ' ' O ' ' A' ' 31' ' ' THR . 1.2 p30 35.42 42.0 0.1 Allowed 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.753 0.787 . . . . 1.39 109.504 178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 31' ' ' THR . 1.2 mm-40 -67.3 161.81 24.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 1.9 110.07 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.681 HG23 ' CE1' ' A' ' 35' ' ' TYR . 9.3 t -90.51 38.78 0.95 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -0.8 . . . . 1.18 109.416 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.681 ' CE1' HG23 ' A' ' 34' ' ' THR . 12.2 m-85 -140.51 -152.57 0.42 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.456 -0.777 . . . . 1.54 108.957 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.476 ' O ' ' CZ ' ' A' ' 58' ' ' ARG . . . -115.5 67.02 0.29 Allowed Glycine 0 N--CA 1.48 1.58 0 N-CA-C 107.697 -2.161 . . . . 0.64 107.697 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 1.05 ' C ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -133.38 31.74 3.73 Favored 'General case' 0 C--O 1.202 -1.424 0 N-CA-C 106.498 -1.668 . . . . 1.14 106.498 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.05 HD13 ' C ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -114.95 60.89 0.69 Allowed 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 107.355 -1.35 . . . . 1.07 107.355 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.914 ' HA ' HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER 179.05 -151.2 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.878 -1.156 . . . . 1.87 107.878 -176.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.901 ' O ' ' HB2' ' A' ' 12' ' ' ALA . . . -74.85 158.59 33.15 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.142 -1.023 . . . . 0.36 108.328 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.099 HG21 ' CE2' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -100.35 -38.55 6.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.106 -1.072 . . . . 0.42 108.106 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.556 ' HG2' ' N ' ' A' ' 43' ' ' TYR . 0.0 OUTLIER 168.84 166.56 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.537 -0.865 . . . . 1.44 109.209 -178.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.616 ' CG ' HG13 ' A' ' 16' ' ' ILE . 2.8 p90 -143.96 118.15 9.54 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.944 -0.762 . . . . 1.31 108.944 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.674 ' HB2' ' HB2' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -94.7 151.67 19.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.724 -1.213 . . . . 0.94 107.724 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.56 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -123.5 129.89 51.89 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.532 -1.355 . . . . 0.64 110.402 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 46' ' ' GLN . 10.4 pt20 -152.67 136.27 16.05 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.416 -0.957 . . . . 1.59 108.416 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.618 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 22.7 m -63.25 -158.54 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 1.5 110.164 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.627 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER 164.85 -50.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.127 -1.435 . . . . 0.62 107.127 -177.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HB1' ' HA ' ' A' ' 74' ' ' PRO . . . 159.5 47.55 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.276 -1.75 . . . . 0.63 106.276 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 51' ' ' THR . . . 155.33 -27.53 0.62 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 106.695 -2.562 . . . . 0.43 106.695 -177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.629 ' CB ' ' O ' ' A' ' 50' ' ' GLY . 29.1 m 108.96 93.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.439 0.696 . . . . 0.43 110.37 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.472 ' OD1' ' HD3' ' A' ' 68' ' ' LYS . 1.6 t-20 -70.56 153.73 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.489 -0.757 . . . . 0.64 110.098 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.619 ' CE1' HG22 ' A' ' 51' ' ' THR . 63.5 m-85 -140.57 131.02 25.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 1.31 108.958 178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' A' ' 43' ' ' TYR . 0.1 OUTLIER -107.01 92.64 4.16 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.509 -0.744 . . . . 1.4 109.164 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.86 HG23 HG23 ' A' ' 16' ' ' ILE . 11.2 mm -94.63 88.22 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.655 -1.278 . . . . 0.48 111.0 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HG3' ' ND1' ' A' ' 66' ' ' HIS . 22.6 tttp -79.24 110.22 14.31 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.074 -1.825 . . . . 1.7 106.074 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.05 147.12 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 118.069 -1.452 . . . . 0.53 110.639 -177.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 1.073 ' HB2' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -96.01 140.62 30.49 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.679 -0.692 . . . . 1.16 110.012 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.965 ' HB2' ' CD1' ' A' ' 65' ' ' LEU . . . -133.28 26.42 4.16 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.193 -1.04 . . . . 0.32 108.193 177.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 37' ' ' LYS . . . 111.03 179.74 20.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.341 -1.504 . . . . 0.44 109.341 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -79.84 -7.88 58.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -1.202 . . . . 1.41 109.349 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.9 -39.29 3.72 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.3 -0.875 . . . . 1.74 109.79 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.649 ' C ' ' HB3' ' A' ' 59' ' ' ALA . 5.0 mttp -98.12 157.45 16.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 1.67 108.606 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 1.099 ' CE2' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -166.01 137.66 3.8 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.526 -1.359 . . . . 1.69 109.148 -178.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.091 ' CD2' HD13 ' A' ' 27' ' ' LEU . 3.7 mp -119.89 -177.26 3.36 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.154 -1.018 . . . . 0.44 109.436 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' ND1' ' HG3' ' A' ' 56' ' ' LYS . 3.3 t60 -162.96 154.14 17.26 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.347 -1.341 . . . . 0.38 111.048 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.108 HD11 ' CD2' ' A' ' 82' ' ' LEU . 25.0 tp -157.42 164.29 37.65 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.001 0.905 . . . . 0.37 109.045 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.746 ' N ' ' HG ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.01 99.15 3.69 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 105.521 -2.029 . . . . 0.45 105.521 176.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.6 ' HA ' ' HG ' ' A' ' 82' ' ' LEU . 90.1 t -82.25 134.43 27.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.157 0 C-N-CA 117.177 -1.809 . . . . 0.38 108.388 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.627 ' CZ ' HG11 ' A' ' 48' ' ' VAL . 3.3 t80 -139.73 122.03 15.98 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.608 -1.308 . . . . 1.27 110.883 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.419 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 25.8 mttt -89.58 67.98 7.62 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.035 -1.098 . . . . 2.16 108.035 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.595 ' HA ' ' CZ ' ' A' ' 70' ' ' PHE . 3.2 m -40.25 131.94 2.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.941 0.877 . . . . 0.73 111.25 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -179.16 60.52 0.12 Allowed Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 107.785 -1.191 . . . . 0.52 107.785 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.809 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . 38.0 Cg_endo -81.02 49.64 3.3 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.735 2.29 . . . . 0.6 110.931 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.22 -48.43 3.62 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.639 -1.385 . . . . 0.77 109.639 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -74.64 -17.87 60.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 2.18 109.553 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.403 HD22 HD12 ' A' ' 73' ' ' LEU . 7.6 t-20 56.73 93.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 0.99 109.298 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 79' ' ' ASP . 49.7 mt-10 -132.01 79.01 1.84 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.287 -0.883 . . . . 2.45 109.401 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 78' ' ' GLU . 0.4 OUTLIER 45.73 -166.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 1.52 109.38 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.869 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.7 OUTLIER -100.34 -147.07 0.35 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 0.86 110.247 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.008 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.9 OUTLIER 179.2 160.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.409 -0.96 . . . . 0.54 108.409 -178.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 1.108 ' CD2' HD11 ' A' ' 67' ' ' LEU . 1.8 mp -146.91 73.92 1.33 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.161 -0.962 . . . . 0.45 109.495 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.4 ' OG1' ' HE2' ' A' ' 68' ' ' LYS . 1.5 m -55.15 -8.86 0.33 Allowed 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.61 -0.836 . . . . 0.58 109.236 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.938 ' O ' HD12 ' A' ' 67' ' ' LEU . . . -115.72 151.93 18.21 Favored Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.011 -1.566 . . . . 0.47 109.676 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 40.3 p90 165.71 121.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.394 -0.965 . . . . 1.89 108.394 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.523 ' CB ' ' OD2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -162.72 154.8 18.53 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.873 -1.142 . . . . 1.92 110.703 -179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.823 HG13 ' N ' ' A' ' 88' ' ' ASP . 4.2 p -90.01 -144.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 108.578 -0.897 . . . . 0.8 108.578 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.823 ' N ' HG13 ' A' ' 87' ' ' VAL . 17.7 p-10 -130.19 -144.34 0.26 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.471 -1.393 . . . . 2.7 110.109 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.526 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 8.7 tttt 81.88 55.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.756 . . . . 2.24 109.361 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 89' ' ' LYS . 0.9 OUTLIER 39.9 37.58 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.654 -0.654 . . . . 1.67 110.557 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 88' ' ' ASP . 45.3 mttt -105.45 -61.24 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 1.45 108.871 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' CB ' ' A' ' 86' ' ' GLN . 2.3 t0 -76.91 6.88 5.47 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.627 -0.829 . . . . 2.23 109.014 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -52.93 149.1 6.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.112 -0.993 . . . . 1.81 109.333 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.425 ' OE1' ' CG2' ' A' ' 2' ' ' ILE . 2.0 mm-40 -179.1 135.39 0.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 2.86 109.305 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.27 163.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 2.74 109.295 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.403 ' CG2' ' HE2' ' A' ' 56' ' ' LYS . 66.0 p -132.12 164.23 26.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.184 -0.948 . . . . 2.97 109.526 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -99.36 -30.56 6.53 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.616 -1.394 . . . . 3.52 109.616 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 6.74 109.436 179.96 . . . . . . . . 1 1 . 1 stop_ save_